UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
August 04, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
July 31, 2020 07:57 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing,...
UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
July 29, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
July 24, 2020 08:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 24, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology Announces CFO Transition
July 06, 2020 17:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 06, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
July 01, 2020 16:05 ET
|
Unity Biotechnology, Inc.
– Topline 12-week results for Phase 2 study of UBX0101 in osteoarthritis expected in 3Q 2020 – – First-in-human study for UBX1325 in age-related eye disease expected to commence in 2H 2020 – SOUTH...
UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
May 07, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting...
UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
May 04, 2020 16:30 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, May 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
March 31, 2020 16:05 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or...
UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
March 30, 2020 17:20 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. today announced that Anirvan Ghosh, Ph.D., has officially joined the company as Chief Executive Officer. As...